Skip to main content
Top
Published in: International Urology and Nephrology 3/2010

01-09-2010 | Urology - Original Paper

Protective effect of Antrodia Camphorata on bladder ischemia/reperfusion injury

Authors: Yung-Shun Juan, Anita Mannikarottu, Shu Mien Chuang, Suning Li, Alpha D. Lin, Lan Chang-Chou, Catherine Schuler, Robert E. Leggett, Robert M. Levin

Published in: International Urology and Nephrology | Issue 3/2010

Login to get access

Abstract

Introduction

Obstructive bladder dysfunction is directly related to ischemia/reperfusion injury characterized by damage to nerves, synapses and smooth muscle cells within the bladder wall. Antrodia Camphorata (AC) has significant antioxidant, antiinflammatory and cell-cycle inhibition properties. The specific aim of this study was to evaluate whether orally administered AC can protect rabbit bladders from the progressive dysfunctions induced by bilateral ischemia/reperfusion (I/R).

Methods

Twenty-four male NZW rabbits were separated into 4 groups of 6 animals each. Rabbits in groups 1 and 2 were fed Antrodia Camphorata (AC) suspensions; those in groups 3 and 4 received vehicle. Each rabbit in groups 2 and 4 were subjected to in vivo bilateral ischemia for 2 h and then allowed to recover for 1 week. The rabbits in groups 1 and 3 received sham operation and served as control groups. Cystometry, contractile responses to field stimulation, carbachol, ATP and KCl were determined. Biochemical and immuno-histochemical studies were also performed.

Results

I/R resulted in decreased compliance, decreased contractile responses, decreased nerve density, and increased apoptosis. AC pretreatment of rabbits subjected to I/R significantly protected the bladder from all contractile, biochemical, and structural dysfunctions resulting in significantly improved bladder.
Literature
2.
go back to reference Levin RM, Levin SS, Zhao Y, Buttyan R (1997) Cellular and molecular aspects of bladder hypertrophy. Eur Urol 32(Suppl 1):15–21PubMed Levin RM, Levin SS, Zhao Y, Buttyan R (1997) Cellular and molecular aspects of bladder hypertrophy. Eur Urol 32(Suppl 1):15–21PubMed
4.
go back to reference Mannikarottu A, Lin AD, Whitebeck C, Leggett R, Kogan B, Levin R (2006) Effect of partial bladder outlet obstruction on nitrotyrosine levels and their correlation with contractile function. Neurourol Urodyn 25:397–401. doi:10.1002/nau.20219 CrossRefPubMed Mannikarottu A, Lin AD, Whitebeck C, Leggett R, Kogan B, Levin R (2006) Effect of partial bladder outlet obstruction on nitrotyrosine levels and their correlation with contractile function. Neurourol Urodyn 25:397–401. doi:10.​1002/​nau.​20219 CrossRefPubMed
8.
go back to reference Lin AD, Mannikarottu A, Kogan BA, Whitbeck C, Leggett RE, Levin RM (2007) Effect of bilateral in vivo ischemia/reperfusion on the activities of superoxide dismutase and catalase: response to a standardized grape suspension. Mol Cell Biochem 296:11–16. doi:10.1007/s11010-005-9068-4 CrossRefPubMed Lin AD, Mannikarottu A, Kogan BA, Whitbeck C, Leggett RE, Levin RM (2007) Effect of bilateral in vivo ischemia/reperfusion on the activities of superoxide dismutase and catalase: response to a standardized grape suspension. Mol Cell Biochem 296:11–16. doi:10.​1007/​s11010-005-9068-4 CrossRefPubMed
9.
10.
go back to reference Liu DZ, Liang HJ, Chen CH et al (2007) Comparative anti-inflammatory characterization of wild fruiting body, liquid-state fermentation, and solid-state culture of Taiwanofungus camphoratus in microglia and the mechanism of its action. J Ethnopharmacol 113:45–53. doi:10.1016/j.jep.2007.03.037 CrossRefPubMed Liu DZ, Liang HJ, Chen CH et al (2007) Comparative anti-inflammatory characterization of wild fruiting body, liquid-state fermentation, and solid-state culture of Taiwanofungus camphoratus in microglia and the mechanism of its action. J Ethnopharmacol 113:45–53. doi:10.​1016/​j.​jep.​2007.​03.​037 CrossRefPubMed
14.
go back to reference Ferlito S (2000) Physiological, metabolic, neuroendocrine and pharmacological regulation of nitric oxide in humans. Minerva Cardioangiol 48:169–176PubMed Ferlito S (2000) Physiological, metabolic, neuroendocrine and pharmacological regulation of nitric oxide in humans. Minerva Cardioangiol 48:169–176PubMed
16.
go back to reference James MJ, Birmingham AT, Hill SJ (1993) Partial mediation by nitric oxide of the relaxation of human isolated detrusor strips in response to electrical field stimulation. Br J Clin Pharmacol 35:366–372PubMed James MJ, Birmingham AT, Hill SJ (1993) Partial mediation by nitric oxide of the relaxation of human isolated detrusor strips in response to electrical field stimulation. Br J Clin Pharmacol 35:366–372PubMed
17.
go back to reference Liu DZ, Liang YC, Lin SY et al (2007) Antihypertensive activities of a solid-state culture of Taiwanofungus camphoratus (Chang-chih) in spontaneously hypertensive rats. Biosci Biotechnol Biochem 71:23–30. doi:10.1271/bbb.60268 CrossRefPubMed Liu DZ, Liang YC, Lin SY et al (2007) Antihypertensive activities of a solid-state culture of Taiwanofungus camphoratus (Chang-chih) in spontaneously hypertensive rats. Biosci Biotechnol Biochem 71:23–30. doi:10.​1271/​bbb.​60268 CrossRefPubMed
23.
Metadata
Title
Protective effect of Antrodia Camphorata on bladder ischemia/reperfusion injury
Authors
Yung-Shun Juan
Anita Mannikarottu
Shu Mien Chuang
Suning Li
Alpha D. Lin
Lan Chang-Chou
Catherine Schuler
Robert E. Leggett
Robert M. Levin
Publication date
01-09-2010
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2010
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9642-x

Other articles of this Issue 3/2010

International Urology and Nephrology 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.